Market research

Plant Biotechnology Equipment

Explore licenses

360iResearch introduction

Plant Biotechnology Equipment: Executive Summary

Plant biotechnology equipment comprises instruments, systems, and laboratory infrastructure used to support plant genomics, tissue culture, molecular biology, phenotyping, transformation, propagation, and controlled-environment research. Demand is shaped by the need for reproducible experiments, contamination control, higher throughput, and improved integration between biological workflows and digital data systems. Applications span academic research, crop improvement, agricultural biotechnology, forestry, conservation, and production of high-value plant material.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Instrument Type

    • Bioreactors
    • DNA Sequencers
    • Microarray Systems
    • PCR Systems
    View chapter
  2. Chapter 8 Technology

    • CRISPR Tools
    • Next Generation Sequencing
    • PCR Technology
    View chapter
  3. Chapter 9 Workflow Stage

    • Analysis
    • Sample Preparation
    • Synthesis
    View chapter

Automation and Standardization Are Reshaping Plant Research

The landscape is shifting from manually intensive laboratory processes toward automated, modular, and data-connected workflows. Liquid handling, imaging, environmental control, sample tracking, and laboratory information management are increasingly coordinated to improve repeatability and reduce operator-dependent variation. At the same time, laboratories are placing greater emphasis on validated protocols, interoperable data formats, biosafety, energy efficiency, and equipment that can be adapted as research programs evolve.

Artificial Intelligence Extends Equipment Intelligence and Workflow Control

Artificial intelligence is contributing to plant biotechnology by accelerating image analysis, phenotypic classification, experimental design, anomaly detection, and interpretation of complex molecular and environmental datasets. Its practical value depends on high-quality, well-labeled data generated through calibrated instruments and consistent workflows. Industry leaders should therefore treat AI as part of an integrated measurement and data architecture rather than as a standalone software feature, while maintaining human review, model validation, cybersecurity, and traceability.

Regional Priorities Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America emphasizes automation, advanced genomics, controlled-environment agriculture, and translational research infrastructure. Europe places strong weight on sustainability, regulatory compliance, collaborative research, and standardized data practices. Asia-Pacific combines large research ecosystems with expanding agricultural biotechnology, food-security, and manufacturing capabilities. Latin America is closely linked to crop productivity, biodiversity, and applied agricultural research, while investment priorities can vary by crop and institution. The Middle East is oriented toward water-efficient cultivation, desert agriculture, and controlled environments. Africa’s requirements center on resilient crops, local research capacity, affordability, maintainability, and technology transfer. Across all regions, service networks, operator training, and reliable utilities are as important as instrument specifications.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Show Distinct Institutional Needs

ASEAN economies are developing collaborative capacity around tropical crops, food security, and agricultural modernization, creating demand for scalable and serviceable laboratory systems. BRICS members encompass diverse research and production environments, with priorities spanning domestic capability, crop resilience, biotechnology infrastructure, and technology localization. The European Union supports cross-border research, sustainability, and regulatory alignment. G7 countries generally have mature research ecosystems and stronger demand for automation, advanced analytics, and reproducibility. GCC members prioritize controlled-environment agriculture and resource efficiency, while NATO members benefit from robust scientific infrastructure but must also consider supply-chain resilience, cybersecurity, and continuity of critical laboratory operations.

Country Priorities Range from Advanced Automation to Capacity Building

Australia emphasizes crop resilience, biosecurity, and research across challenging environments. Brazil focuses on agricultural productivity, tropical systems, and biotechnology applied to major crops. Canada combines genomics, controlled environments, and research addressing climate variability. China is advancing integrated agricultural research, automation, and domestic laboratory capabilities. France, Germany, Italy, Spain, and the United Kingdom maintain strong interests in plant science, sustainability, and research standardization, with differing institutional and crop priorities. India emphasizes food security, agricultural innovation, affordability, and scalable laboratory capacity. Japan and South Korea are strongly oriented toward precision systems, automation, and high-quality research workflows. Mexico combines crop improvement, environmental adaptation, and applied agricultural research. Russia’s priorities include crop resilience, domestic scientific capacity, and supply-chain reliability. The United States continues to support advanced genomics, phenotyping, automation, and data-intensive plant research.

Prioritize Interoperability, Serviceability, and Evidence-Based Automation

Industry leaders should build equipment strategies around complete workflows rather than isolated instruments. Priorities include interoperable hardware and software, open data export, modular upgrades, calibration controls, contamination prevention, and documented validation. Procurement decisions should evaluate total operating requirements, including training, maintenance, consumables, utilities, cybersecurity, and local technical support. Organizations should introduce AI where it addresses a defined bottleneck, establish governance for model performance and data quality, and use pilot projects with measurable operational criteria before broader deployment. Regional partnerships, workforce development, and resilient sourcing can further improve adoption and continuity.

Methodology: Structured Synthesis of Plant Biotechnology Equipment Drivers

This executive summary uses a structured qualitative assessment of the plant biotechnology equipment domain. The analysis organizes the field by laboratory function, technology maturity, workflow requirements, regional conditions, institutional groupings, and national research priorities. It emphasizes observable themes including automation, data integration, controlled environments, reproducibility, sustainability, biosafety, workforce capability, and supply-chain resilience. No market estimates, market shares, forecasts, or company-specific claims are used. The conclusions should be validated against current procurement records, regulatory requirements, facility capabilities, and primary interviews before investment decisions are made.

Integrated, Adaptable Infrastructure Will Define Long-Term Competitiveness

Plant biotechnology equipment is evolving into a connected infrastructure layer for faster, more reproducible, and more resource-conscious plant research. The strongest strategies will combine fit-for-purpose instrumentation with automation, reliable data practices, skilled personnel, and responsive service models. Regional and national priorities differ, but the common requirements are clear: dependable performance, interoperability, validated workflows, responsible AI adoption, and resilience across the equipment lifecycle. Leaders that align these elements can strengthen research quality while remaining adaptable to changing biological, regulatory, and environmental demands.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Plant Biotechnology Equipment Market, by Instrument Type
    1. 7.1Introduction
    2. 7.2Bioreactors
      1. 7.2.1Single Use
      2. 7.2.2Stainless Steel
    3. 7.3DNA Sequencers
      1. 7.3.1Next Generation Sequencing
      2. 7.3.2Sanger Sequencing
    4. 7.4Microarray Systems
      1. 7.4.1Gene Expression
      2. 7.4.2SNP Analysis
    5. 7.5PCR Systems
  8. 8.Plant Biotechnology Equipment Market, by Technology
    1. 8.1Introduction
    2. 8.2CRISPR Tools
      1. 8.2.1Plasmid Delivery
      2. 8.2.2Ribonucleoprotein
    3. 8.3Next Generation Sequencing
    4. 8.4PCR Technology
  9. 9.Plant Biotechnology Equipment Market, by Workflow Stage
    1. 9.1Introduction
    2. 9.2Analysis
      1. 9.2.1Bioinformatics
      2. 9.2.2Data Visualization
    3. 9.3Sample Preparation
      1. 9.3.1DNA Extraction
      2. 9.3.2Library Preparation
    4. 9.4Synthesis
      1. 9.4.1Gene Synthesis
      2. 9.4.2Oligo Synthesis
  10. 10.Plant Biotechnology Equipment Market, by Application
    1. 10.1Introduction
    2. 10.2Gene Editing
    3. 10.3Genetic Analysis
      1. 10.3.1Expression Analysis
      2. 10.3.2Genotyping
    4. 10.4Phenotyping
      1. 10.4.1Image Analysis
      2. 10.4.2Sensor Based
    5. 10.5Tissue Culture
      1. 10.5.1Callus Culture
      2. 10.5.2Protoplast Culture
  11. 11.Plant Biotechnology Equipment Market, by End User
    1. 11.1Introduction
    2. 11.2Academic Institutions
      1. 11.2.1Research Centers
      2. 11.2.2Universities
    3. 11.3Biotech Companies
      1. 11.3.1Agri Biotech
      2. 11.3.2Pharma Biotech
    4. 11.4Contract Research Organizations
    5. 11.5Pharma Companies
  12. 12.Plant Biotechnology Equipment Market, by Region
    1. 12.1Introduction
    2. 12.2Asia-Pacific
    3. 12.3North America
    4. 12.4Latin America
    5. 12.5Europe
    6. 12.6Middle East
    7. 12.7Africa
  13. 13.Plant Biotechnology Equipment Market, by Group
    1. 13.1Introduction
    2. 13.2ASEAN
    3. 13.3GCC
    4. 13.4European Union
    5. 13.5BRICS
    6. 13.6G7
    7. 13.7NATO
  14. 14.Plant Biotechnology Equipment Market, by Country
    1. 14.1Introduction
    2. 14.2United States
    3. 14.3Canada
    4. 14.4Mexico
    5. 14.5Brazil
    6. 14.6United Kingdom
    7. 14.7Germany
    8. 14.8France
    9. 14.9Russia
    10. 14.10Italy
    11. 14.11Spain
    12. 14.12China
    13. 14.13India
    14. 14.14Japan
    15. 14.15Australia
    16. 14.16South Korea
  15. 15.Competitive Landscape
    1. 15.1Market Share Analysis, 2025
    2. 15.2Market Concentration Analysis, 2025
      1. 15.2.1Concentration Ratio (CR)
      2. 15.2.2Herfindahl Hirschman Index (HHI)
    3. 15.3Recent Developments & Impact Analysis, 2025
    4. 15.4Product Portfolio Analysis, 2025
    5. 15.5Benchmarking Analysis, 2025
  16. 16.Company Profiles
    1. 16.1ACMAS Technologies Pvt. Ltd.
    2. 16.2Bionics Scientific Technologies (P) Ltd.
    3. 16.3Danaher Corporation
    4. 16.4Evogene Ltd.
    5. 16.5Heinz Walz GmbH
    6. 16.6Illumina, Inc.
    7. 16.7KeyGene N.V.
    8. 16.8LabRepCo, LLC
    9. 16.9LemnaTec GmbH
    10. 16.10LGC Limited
    11. 16.11Microsil India Pvt. Ltd.
    12. 16.12Narang Scientific Works Pvt. Ltd.
    13. 16.13Neu-tec Group Inc.
    14. 16.14PhytoTech Labs
    15. 16.15PSI (Photon Systems Instruments) spol. s r.o.
    16. 16.16Qubit Systems Inc.
    17. 16.17S.K. APPLIANCES
    18. 16.18Tecan Group AG
    19. 16.19Thermo Fisher Scientific Inc.
  17. 17.Key Experts

Loading the sample request form…